Hypothalamic loss of Snord116 and Prader-Willi syndrome hyperphagia: The buck stops here?

Juan A. Rodriguez, Jeffrey M. Zigman

Research output: Contribution to journalReview article

4 Scopus citations

Abstract

Hyperphagia and obesity are the best-known manifestations of Prader-Willi syndrome (PWS) and are responsible for most of the overall morbidity and mortality associated with the disease. Yet these PWS symptoms remain poorly understood and without effective pharmacologic therapies. Mouse models attempting to recapitulate both the genetic alterations and marked hyperphagia plus obesity of PWS have been enigmatic, leading to skepticism about the use of mouse models to investigate PWS. In this issue of the JCI, Polex-Wolf and colleagues challenge the skeptics by successfully inducing hyperphagia following bilateral mediobasal hypothalamic deletion of the Snord116 gene from adult mice. Obesity also resulted, although only in a subset of mice. While this approach represents an exciting advance, highlighting a pathologic effect of loss of mediobasal hypothalamic Snord116 expression on the development of PWS's hallmark symptoms, the variability in the body-weight and body composition responses to this siteselective gene deletion raises several questions.

Original languageEnglish (US)
Pages (from-to)900-902
Number of pages3
JournalJournal of Clinical Investigation
Volume128
Issue number3
DOIs
StatePublished - Mar 1 2018

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Hypothalamic loss of Snord116 and Prader-Willi syndrome hyperphagia: The buck stops here?'. Together they form a unique fingerprint.

  • Cite this